Bertrand Billemont

Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network

Gabriel G. Malouf, Philippe Camparo, Stéphane Oudard et al. · Annals of Oncology · 2010 · 229 citations · Full text

Medicine, Cancer Biology, Oncology +12

Systemic mastocytosis and bone involvement in a cohort of 75 patients

Stéphane Barète, Noémie Assous, C. De Gennes et al. · Annals of the Rheumatic Diseases · 2010 · 162 citations

Medicine, Orthopedic Surgery, Radiology +17

Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice

Benoı̂t Blanchet, Bertrand Billemont, Julie Cramard et al. · Journal of Pharmaceutical and Biomedical Analysis · 2009 · 119 citations

Pharmacy, Pharmacokinetics, Pharmacology +7

Variability of Sorafenib Toxicity and Exposure over Time: A Pharmacokinetic/Pharmacodynamic Analysis

Pascaline Boudou‐Rouquette, Stanislas Ropert, Olivier Mir et al. · The Oncologist · 2012 · 104 citations · Full text

Medicine, Oncology, Pharmacology +17

Transcription Factor E3 and Transcription Factor EB Renal Cell Carcinomas: Clinical Features, Biological Behavior and Prognostic Factors

Gabriel G. Malouf, Philippe Camparo, Vincent Molinié et al. · The Journal of Urology · 2010 · 102 citations

Medicine, Cancer Biology, Oncology +16